🔎 Trials Near Me

Akèy › Gliyoblastòm › Pennsylvania › Pittsburgh

Etid klinik pou Gliyoblastòm nan Pittsburgh, PA

9 etid pou Gliyoblastòm ap chèche patisipan nan sit nan ak bò kote Pittsburgh (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

Ap rekriteFaz 3
  • Allegheny Health Network, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT07195591

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

Ap rekriteFaz 1/2
  • UPMC Hillman Cancer Center, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05432804

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Ap rekriteFaz 2/3
  • University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT03970447

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Ap rekriteFaz 2
  • UPMC Hillman Cancer Center, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07326566

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Ap rekriteFaz 1
  • UPMC Hillman Cancer Center, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06860594

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Ap rekriteFaz 3
  • UPMC Hillman Cancer Center, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

Ap rekriteFaz 2
  • University of Pittsburgh Medical Center, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT02977780

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

Ap rekriteFaz 2
  • UPMC Presbyterian Hospital, Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Jul 1, 2026 · NCT06805305

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Ap rekriteFaz 1
  • University of Pittsburg Medical Center (UPCM), Pittsburgh
Laj 18 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT05283330

Etid Gliyoblastòm nan lòt vil

Lòt etid nan Pittsburgh

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.